Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.
How to buy Collegium Pharmaceutical (COLL) stocks in Canada
Learn how to easily invest in Collegium Pharmaceutical stocks.
Collegium Pharmaceutical is a drug manufacturers-specialty & generic business based in the US. Collegium Pharmaceutical stocks (COLL.US) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $22.54 – an increase of 5.48% over the previous week. Collegium Pharmaceutical employs 152 staff and has a trailing 12-month revenue of around $272.9 million.
How to buy stocks in Collegium Pharmaceutical
- Compare stock trading platforms. Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – COLL – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of stocks with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
What's in this guide?
- Can I buy shares in Collegium Pharmaceutical?
- Has coronavirus impacted Collegium Pharmaceutical shares?
- Collegium Pharmaceutical shares summary
- Compare share dealing platforms
- Is Collegium Pharmaceutical stock a buy or sell?
- Collegium Pharmaceutical performance over time
- Are Collegium Pharmaceutical shares over-valued?
- Collegium Pharmaceutical's financials
- How volatile are Collegium Pharmaceutical shares?
- Does Collegium Pharmaceutical pay a dividend?
- Other common questions
Collegium Pharmaceutical stock price (NASDAQ:COLL)Use our graph to track the performance of COLL stocks over time.
Collegium Pharmaceutical shares at a glance
|Latest market close||$16.36|
|52-week range||$14.04 - $25.66|
|50-day moving average||$17.80|
|200-day moving average||$19.04|
|Wall St. target price||$28.86|
|Dividend yield||$0 (0%)|
|Earnings per share (TTM)||$1.18|
Compare stock trading platforms
Note: The dollar amounts in the table below are in Canadian dollars.
Is it a good time to buy Collegium Pharmaceutical stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
Collegium Pharmaceutical price performance over time
|1 week (2022-05-16)||5.48%|
|1 month (2022-04-20)||-9.26%|
|3 months (2022-02-20)||N/A|
|6 months (2021-11-24)||-11.71%|
|1 year (2021-05-24)||-33.28%|
|2 years (2020-05-22)||-27.35%|
|3 years (2019-05-24)||38.18%|
|5 years (2017-05-24)||75.35%|
Is Collegium Pharmaceutical under- or over-valued?
Valuing Collegium Pharmaceutical stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Collegium Pharmaceutical's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Collegium Pharmaceutical's P/E ratio
Collegium Pharmaceutical's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 14x. In other words, Collegium Pharmaceutical shares trade at around 14x recent earnings.
That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.
Collegium Pharmaceutical's EBITDA
Collegium Pharmaceutical's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $91.8 million.
The EBITDA is a measure of a Collegium Pharmaceutical's overall financial performance and is widely used to measure a its profitability.
Collegium Pharmaceutical financials
|Revenue TTM||$272.9 million|
|Operating margin TTM||7.49%|
|Gross profit TTM||$217.8 million|
|Return on assets TTM||1.35%|
|Return on equity TTM||23.37%|
|Market capitalisation||$554.4 million|
TTM: trailing 12 months
Collegium Pharmaceutical share dividends
We're not expecting Collegium Pharmaceutical to pay a dividend over the next 12 months.
Collegium Pharmaceutical share price volatility
Over the last 12 months, Collegium Pharmaceutical's shares have ranged in value from as little as $14.04 up to $25.66. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Collegium Pharmaceutical's is 1.0603. This would suggest that Collegium Pharmaceutical's shares are a little bit more volatile than the average for this exchange and represent, relatively-speaking, a slightly higher risk (but potentially also market-beating returns).
Collegium Pharmaceutical overview
Collegium Pharmaceutical, Inc. , a specialty pharmaceutical company, develops and commercializes medicines for pain management. Its portfolio includes Xtampza ER, an abuse-deterrent, extended-release, oral formulation of oxycodone; Nucynta ER and Nucynta IR, which are extended-release and immediate-release formulations of tapentadol; and Xtampza ER for the management of pain severe enough to require daily, around-the-clock, long-term opioid treatment. The company was formerly known as Collegium Pharmaceuticals, Inc. and changed its name to Collegium Pharmaceutical, Inc. in October 2003. Collegium Pharmaceutical, Inc.
Stocks similar to Collegium Pharmaceutical
Collegium Pharmaceutical in the news
Collegium Pharmaceutical : Statement of Changes in Beneficial Ownership (Form 4)
COLLEGIUM PHARMACEUTICAL, INC : Submission of Matters to a Vote of Security Holders (form 8-K)
Collegium to Participate in H.C. Wainwright Global Investment Conference
Frequently asked questions
Disclaimer: This information should not be interpreted as an endorsement of futures, stocks, ETFs, options or any specific provider, service or offering. It should not be relied upon as investment advice or construed as providing recommendations of any kind. Futures, stocks, ETFs and options trading involves substantial risk of loss and therefore are not appropriate for all investors. Trading forex on leverage comes with a higher risk of losing money rapidly. Past performance is not an indication of future results. Consider your own circumstances, and obtain your own advice, before making any trades.
More on investing
iGaming is now legal in Ontario. Find out which companies to keep an eye on with our list of 10 top online gaming stocks.Read more…
Enjoy perks like free trades and cash rewards when you open a stock trading account with these online brokers.Read more…
Here’s what you need to know about investing in the propane industry, including 3 popular propane stocks to watch.Read more…
More guides on Finder
Apps like Wealthsimple
Learn more about apps like Wealthsimple to find the best trading platform for your unique set of needs.
Online gaming stocks
iGaming is now legal in Ontario. Find out which companies to keep an eye on with our list of 10 top online gaming stocks.
How to buy Entain stock in Canada
Steps to owning and managing ENT stock, with 24-hour and historical pricing before you buy.
How to buy Kambi Group stock in Canada
Steps to owning and managing KAMBI stock, with 24-hour and historical pricing before you buy.
Best brokerage signup bonuses in 2022
Enjoy perks like free trades and cash rewards when you open a stock trading account with these online brokers.
How to buy Rush Street Interactive stock in Canada
Steps to owning and managing RSI stock, with 24-hour and historical pricing before you buy.
How to buy PointsBet stock in Canada
Steps to owning and managing PBTHF stock, with 24-hour and historical pricing before you buy.
How to buy Hanover Bancorp, Inc. (HNVR) stock in Canada when it goes public
Everything we know about the Hanover Bancorp, Inc. IPO, plus information on how to buy in.
How to buy PrimeBlock stock in Canada when it goes public
Everything we know about the PrimeBlock IPO, plus information on how to buy in.
How to buy Actelis Networks (ASNS) stock in Canada
Everything we know about the Actelis Networks IPO, plus information on how to buy in.
Ask an Expert
You must be logged in to post a comment.